Documento de consenso sobre el diagnóstico y tratamiento de la infección bronquial crónica en la enfermedad pulmonar obstructiva crónica
…, JJS Cataluña, JAF Villar, GPB Romero - Archivos de …, 2020 - Elsevier
A pesar de que es conocido que la presencia crónica de microorganismos en las vías
aéreas de pacientes con enfermedad pulmonar obstructiva crónica (EPOC) en fase de …
aéreas de pacientes con enfermedad pulmonar obstructiva crónica (EPOC) en fase de …
Evolución comparativa con ventilación no invasiva de pacientes con EPOC, síndrome de hipoventilación-obesidad e insuficiencia cardíaca congestiva ingresados en …
ÁO González, GPB Romero, IF Ormaechea… - Archivos de …, 2006 - Elsevier
Objetivo Hemos realizado un trabajo comparativo en pacientes con enfermedad pulmonar
obstructiva crónica (EPOC), síndrome de hipoventilación-obesidad (SHO) e insuficiencia …
obstructiva crónica (EPOC), síndrome de hipoventilación-obesidad (SHO) e insuficiencia …
Marcadores pronósticos en la EPOC. Papel de la comorbilidad
FV Álvarez, GPB Romero - Archivos de Bronconeumología, 2009 - Elsevier
Una enfermedad crónica como la enfermedad pulmonar obstructiva crónica (EPOC) debe
tener necesariamente marcadores que pueden influir en su evolución o historia natural. El …
tener necesariamente marcadores que pueden influir en su evolución o historia natural. El …
[HTML][HTML] Identifying COPD patients with poor health status and low exercise tolerance through the five-repetition sit-to-stand test and modified Medical Research …
…, FG Río, L Puente, J Ancochea, GPB Romero… - European Journal of …, 2024 - Elsevier
Background The objective of this study was to determine whether the concomitant presence
of poor health status (COPD Assessment Test, CAT ≥ 10 points) and low exercise tolerance …
of poor health status (COPD Assessment Test, CAT ≥ 10 points) and low exercise tolerance …
[HTML][HTML] Compassionate use of tocilizumab in severe SARS-CoV2 pneumonia
…, FR Bueno, S Heili-Frades, GPB Romero - International Journal of …, 2021 - Elsevier
Introduction Tocilizumab is an interleukin 6 receptor antagonist which has been used for the
treatment of severe SARS-CoV-2 pneumonia (SSP), aiming to ameliorate the cytokine …
treatment of severe SARS-CoV-2 pneumonia (SSP), aiming to ameliorate the cytokine …
Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD
…, M Divo, A Fuster, G Peces-Barba… - European …, 2017 - Eur Respiratory Soc
The impact of blood eosinophilia in chronic obstructive pulmonary disease (COPD) remains
controversial. To evaluate the prevalence and stability of a high level of blood eosinophils (…
controversial. To evaluate the prevalence and stability of a high level of blood eosinophils (…
Evolution of patients with chronic obstructive pulmonary disease, obesity hypoventilation syndrome, or congestive heart failure undergoing noninvasive ventilation in a …
ÁO González, GPB Romero, IF Ormaechea… - Archivos de …, 2006 - Elsevier
OBJECTIVE: We compared the use of noninvasive ventilation (NIV) for hypercanic acidosis
with hypoxemia in patients with chronic obstructive pulmonary disease (COPD), obesity …
with hypoxemia in patients with chronic obstructive pulmonary disease (COPD), obesity …
COVID-19 Outcomes in 4712 consecutively confirmed SARS-CoV2 cases in the city of Madrid
…, MJR Nieto, GPB Romero, M Peces-Barba… - MedRxiv, 2020 - medrxiv.org
There is limited information describing features and outcomes of patients requiring
hospitalization for COVID19 disease and still no treatments have clearly demonstrated efficacy. …
hospitalization for COVID19 disease and still no treatments have clearly demonstrated efficacy. …
Elevated levels of arginase activity are related to inflammation in patients with COPD exacerbation
MJ Rodríguez-Guzmán, G Peces-Barba Romero… - BMC Pulmonary …, 2021 - Springer
Introduction Within the pathogenesis of the chronic obstructive pulmonary disease (COPD)
there are interactions between different inflammatory mediators that are enhanced during an …
there are interactions between different inflammatory mediators that are enhanced during an …
Compassionate Use of Tocilizumab in Severe SARS-CoV2 Pneumonia. When late administration is too late
Introduction Tocilizumab is an interleukin 6 receptor antagonist which has been used for the
treatment of severe SARS-CoV-2 pneumonia (SSP), aiming to ameliorate the cytokine …
treatment of severe SARS-CoV-2 pneumonia (SSP), aiming to ameliorate the cytokine …
